Journal article icon

Journal article

Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.

Abstract:

BACKGROUND: Octreotide treatment may be associated with gall stone development in up to 50% of patients with acromegaly. Two new sustained-release formulations of somatostatin analogue have been recently developed: lanreotide SR (Somatuline) and octreotide LAR (Sandostatin LAR). The incidence of gall-stone development in patients receiving these drugs has been shown to be less than 20%, but the duration of follow-up has been limited. OBJECTIVE: Prospectively to assess and compare the effects ...

Expand abstract

Actions


Access Document


Publisher copy:
10.1530/eje.0.1410590

Authors


Journal:
European journal of endocrinology / European Federation of Endocrine Societies
Volume:
141
Issue:
6
Pages:
590-594
Publication date:
1999-12-05
DOI:
EISSN:
1479-683X
ISSN:
0804-4643
URN:
uuid:538e9a22-292a-4ca7-babf-e5c94b8c1f7f
Source identifiers:
17313
Local pid:
pubs:17313

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP